Login

Orbis' CEO Jani Linna-Aro interviews Phil Stanway from Huber+Suhner AG about their partnership and business insights. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Colin Lynch Discusses the Impact of the Black Opportunity Fund on The News Forum | Colin Lynch, Managing Director at TD Asset Management
00:10:00
Orsu Metals Corporation Presentation
00:10:00
Future of L&T Mutual Funds: Continuity Amidst HSBC Integration | Mr. Kailash Kulkarni, CEO , L&T Mutual Fund .
00:10:00
Point72 ventures wants to invest in founders who are passionate, knowledgeable|Sri Chandrasekar,Managing Partner,Point72 Ventures
00:10:00
Stonewall Kitchen Secures Investment from Center Partners: A Sweet Success Story
00:10:00
Steadfast Growth and Resilience: Nordea's 2023 Recap | Frank Vang-Jensen, CEO, Nordea .
00:10:00
KKR Co-CEOs Joe Bae and Scott Nuttall on Ambitious Growth Targets and Japanese Market Opportunities
00:10:00
Brian Mattingley on 888 Holdings: Navigating European Markets and Adapting to UK Changes | Chip Paucek, CEO , 2U Inc.
00:10:00
Sustainable Tailings Recycling in South African Gold Mining
00:10:00
Meet Christina Gayman: Syverson Strege Team | Christina Gayman - Director of Communications & Marketing of Syverson Strege
00:10:00
Introducing M1's Owner's Rewards Credit Card: A Unique Integration of Spending and Investing
00:10:00
Purdue Foundry Invests in High-tech Startups|Bill Arnold,Assistant Vice President,Heritage Grocers Group

© 2017 - Neuhu+